BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1717024)

  • 1. Evaluation of immunocytochemical staining as a method of improving diagnostic accuracy in a routine cytopathology laboratory.
    Wazir JF; Martin-Bates E; Woodward G; Coleman DV
    Cytopathology; 1991; 2(2):75-82. PubMed ID: 1717024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical panel for the identification of malignant cells in serous effusions.
    Nance KV; Silverman JF
    Am J Clin Pathol; 1991 Jun; 95(6):867-74. PubMed ID: 1710419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
    Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP
    Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.
    Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W
    Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical staining of cytologic specimens. How helpful is it?
    Shield PW; Perkins G; Wright RG
    Am J Clin Pathol; 1996 Feb; 105(2):157-62. PubMed ID: 8607438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE COMPARATIVE DIAGNOSTIC ACCURACY, EFFICIENCY AND SPECIFICITY OF CYTOLOGIC TECHNICS USED IN THE DIAGNOSIS OF MALIGNANT NEOPLASM IN SEROUS EFFUSIONS OF THE PLEURAL AND PERICARDIAL CAVITIES.
    GRUNZE H
    Acta Cytol; 1964; 8():150-63. PubMed ID: 14154149
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions.
    Metzgeroth G; Kuhn C; Schultheis B; Hehlmann R; Hastka J
    Cytopathology; 2008 Aug; 19(4):205-11. PubMed ID: 17573908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in the cytodiagnosis of serous effusions.
    al-Nafussi A; Carder PJ
    Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of carcinoembryonic antigen levels in serous effusions. Correlation with cytology.
    Whiteside TL; Dekker A
    Acta Cytol; 1979; 23(6):443-8. PubMed ID: 295160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of immunocytochemical assays in the study of exudates from serous cavities in the practical work of a laboratory].
    Grigoruk OG; Bazulina LM; Lazarev AF
    Klin Lab Diagn; 2008 Jan; (1):20-2, 35-6. PubMed ID: 18314775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effusion cytology.
    Ehya H
    Clin Lab Med; 1991 Jun; 11(2):443-67. PubMed ID: 1873966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEA, ZGM and EMA localization in cells of pleural and peritoneal effusion: a preliminary study.
    O'Brien MJ; Kirkham SE; Burke B; Ormerod M; Saravis CA; Gottlieb LS; Neville AM; Zamcheck N
    Invest Cell Pathol; 1980; 3(3):251-8. PubMed ID: 6159337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine needle aspiration (FNA) biopsy of orbital masses: a critical review of 51 cases.
    Zeppa P; Tranfa F; Errico ME; Troncone G; Fulciniti F; Vetrani A; Bonavolontà G; Palombini L
    Cytopathology; 1997 Dec; 8(6):366-72. PubMed ID: 9439888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
    Chen CJ; Chang SC; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic markers in the cytological diagnosis of human malignant neoplasms].
    Frank GA; Pugachev KK; Shabalova IP; Shimbireva IB
    Arkh Patol; 1990; 52(8):70-4. PubMed ID: 2281989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of fibronectin in immuocytochemial differentiation of reactive mesothelial cells from metastatic malignant cells in serous effusions.
    Agarwal C; Jain M
    Indian J Pathol Microbiol; 2009; 52(1):25-8. PubMed ID: 19136774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular testing on serous effusions.
    Davidson B
    Diagn Cytopathol; 2021 May; 49(5):640-646. PubMed ID: 32023012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.